Literature DB >> 33130315

Sex differences in health and disease: A review of biological sex differences relevant to cancer with a spotlight on glioma.

Susan Christine Massey1, Paula Whitmire1, Tatum E Doyle2, Joseph E Ippolito3, Maciej M Mrugala4, Leland S Hu5, Peter Canoll6, Alexander R A Anderson7, Melissa A Wilson8, Susan M Fitzpatrick9, Margaret M McCarthy10, Joshua B Rubin11, Kristin R Swanson12.   

Abstract

The influence of biological sex differences on human health and disease, while being increasingly recognized, has long been underappreciated and underexplored. While humans of all sexes are more alike than different, there is evidence for sex differences in the most basic aspects of human biology and these differences have consequences for the etiology and pathophysiology of many diseases. In a disease like cancer, these consequences manifest in the sex biases in incidence and outcome of many cancer types. The ability to deliver precise, targeted therapies to complex cancer cases is limited by our current understanding of the underlying sex differences. Gaining a better understanding of the implications and interplay of sex differences in diseases like cancer will thus be informative for clinical practice and biological research. Here we review the evidence for a broad array of biological sex differences in humans and discuss how these differences may relate to observed sex differences in various diseases, including many cancers and specifically glioblastoma. We focus on areas of human biology that play vital roles in healthy and disease states, including metabolism, development, hormones, and the immune system, and emphasize that the intersection of sex differences in these areas should not go overlooked. We further propose that mathematical approaches can be useful for exploring the extent to which sex differences affect disease outcomes and accounting for those in the development of therapeutic strategies.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Glioma; Patient-specific computational modeling; Precision medicine; Sex differences; Sex factors

Year:  2020        PMID: 33130315     DOI: 10.1016/j.canlet.2020.07.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Sex Differences in Glioblastoma-Findings from the Swedish National Quality Registry for Primary Brain Tumors between 1999-2018.

Authors:  Björn Tavelin; Annika Malmström
Journal:  J Clin Med       Date:  2022-01-18       Impact factor: 4.241

2.  Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy.

Authors:  Alexander B Brummer; Xin Yang; Eric Ma; Margarita Gutova; Christine E Brown; Russell C Rockne
Journal:  PLoS Comput Biol       Date:  2022-01-26       Impact factor: 4.475

Review 3.  Bias and Class Imbalance in Oncologic Data-Towards Inclusive and Transferrable AI in Large Scale Oncology Data Sets.

Authors:  Erdal Tasci; Ying Zhuge; Kevin Camphausen; Andra V Krauze
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

4.  Serum microRNA-4297 is a sex-specific predictive biomarker of glioma grade and prognosis.

Authors:  Wenshen Xu; Liming Huang; Bingsen Xie; Bin Yang
Journal:  Front Neurol       Date:  2022-07-27       Impact factor: 4.086

5.  Treatment providers' perspectives on a gender-responsive approach in alcohol and drug treatment for women in Belgium.

Authors:  Julie Schamp; Wouter Vanderplasschen; Florien Meulewaeter
Journal:  Front Psychiatry       Date:  2022-08-30       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.